Iradimed (IRMD) Change in Account Payables (2013 - 2026)
Iradimed's (IRMD) quarterly Change in Account Payables came in at $362000.0 in Q1 2026, down 47.84% year-on-year from $694000.0 in Q1 2025, and up 170.56% on a QoQ basis from -$513069.0 in Q4 2025.
Iradimed (IRMD) Change in Account Payables (2013 - 2026) Analysis & Trends
Iradimed (IRMD) has 14 years of Change in Account Payables data on file, last reported at $362000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 47.84% year-over-year to $362000.0 in Q1 2026; TTM through Mar 2026 was -$408000.0, a 186.38% decrease from a year earlier, with the FY2025 full-year figure at -$76000.0, up 91.18% from the prior year.
- Change in Account Payables for Q1 2026 stood at $362000.0, up from -$513069.0 in the prior quarter.
- Over the last five years, Change in Account Payables for IRMD reached as high as $1.6 million in Q2 2023 and fell as low as -$1.2 million in Q3 2023.
- Historically, Change in Account Payables has averaged $19560.9 across 5 years, with a median of $52960.0 in 2022.
- On a YoY basis, Change in Account Payables climbed as much as 2190.24% in 2022 and fell as far as 6104.67% in 2022.
- Year by year, Change in Account Payables stood at $1.1 million in 2022, then plunged by 167.68% to -$736084.0 in 2023, then surged by 47.26% to -$388180.0 in 2024, then slumped by 32.17% to -$513069.0 in 2025, then jumped by 170.56% to $362000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $362000.0 in Q1 2026, -$513069.0 in Q4 2025, and $432494.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iradimed | 1.20 Bn | 1.14 Bn | 16.81 Mn | 362,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 362,000.00 |
| Mar 31, 2026 | 362,000.00 |
| Dec 31, 2025 | -513,069.00 |
| Dec 31, 2025 | -513,069.00 |
| Sep 30, 2025 | 432,494.00 |
| Sep 30, 2025 | 432,494.00 |
| Jun 30, 2025 | -689,425.00 |
| Jun 30, 2025 | -689,425.00 |
| Mar 31, 2025 | 694,000.00 |
| Mar 31, 2025 | 694,000.00 |
| Dec 31, 2024 | -388,180.00 |
| Dec 31, 2024 | -388,180.00 |
| Sep 30, 2024 | 289,056.00 |
| Sep 30, 2024 | 289,056.00 |
| Jun 30, 2024 | -122,556.00 |
| Jun 30, 2024 | -122,556.00 |
| Mar 31, 2024 | -640,320.00 |
| Mar 31, 2024 | -640,320.00 |
| Dec 31, 2023 | -736,084.00 |
| Dec 31, 2023 | -736,084.00 |